| Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma. | Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.
Matull J, Placke JM, Lodde G, Zaremba A, Utikal J, Terheyden P, Pföhler C, Herbst R, Kreuter A, Welzel J, Kretz J, Möller I, Sucker A, Paschen A, Livingstone E, Zimmer L, Hadaschik E, Ugurel S, Schadendorf D, Thielmann CM, Griewank KG., Free PMC Article | 10/28/2024 |
| The elusive BAP1 mutation in pediatric melanocytic tumors. | The elusive BAP1 mutation in pediatric melanocytic tumors.
Moustafa D, Mologousis MA, Duncan LM, Hawryluk EB. | 10/1/2024 |
| Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series. | Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series.
Miranda J, Dave P, Kemel Y, Sheikh R, Zong G, Calderon LP, Will M, Liu YL, Walsh M, Stadler ZK, Offit K, Latham A, Mandelker D, Chen YB, Andrieu PC, Carlo MI., Free PMC Article | 09/10/2024 |
| Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status. | Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status.
Gelmi MC, de Ru AH, van Veelen PA, Tjokrodirijo RTN, Stern MH, Houy A, Verdijk RM, Vu THK, Ksander BR, Vaarwater J, Kilic E, Brosens E, Jager MJ., Free PMC Article | 08/23/2024 |
| Saturation genome editing of BAP1 functionally classifies somatic and germline variants. | Saturation genome editing of BAP1 functionally classifies somatic and germline variants.
Waters AJ, Brendler-Spaeth T, Smith D, Offord V, Tan HK, Zhao Y, Obolenski S, Nielsen M, van Doorn R, Murphy JE, Gupta P, Rowlands CF, Hanson H, Delage E, Thomas M, Radford EJ, Gerety SS, Turnbull C, Perry JRB, Hurles ME, Adams DJ., Free PMC Article | 08/13/2024 |
| [Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma]. | [Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma].
Bai YF, Weng MH, He JJ, Xu LM, Chang CD, Teng XD. | 08/7/2024 |
| ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures. | ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures.
Li J, Cao D, Jiang L, Zheng Y, Shao S, Zhuang A, Xiang D. | 07/24/2024 |
| Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. | Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress.
Chua V, Lopez-Anton M, Mizue Terai, Ryota Tanaka, Baqai U, Purwin TJ, Haj JI, Waltrich FJ Jr, Trachtenberg I, Luo K, Tudi R, Jeon A, Han A, Chervoneva I, Davies MA, Aguirre-Ghiso JA, Sato T, Aplin AE., | 06/15/2024 |
| BAP1 controls mesenchymal stem cell migration by inhibiting the ERK signaling pathway. | BAP1 controls mesenchymal stem cell migration by inhibiting the ERK signaling pathway.
Kim S, Lee EW, Oh DB, Seo J., Free PMC Article | 06/10/2024 |
| The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK. | The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
Sato H, Ito T, Hayashi T, Kitano S, Erdjument-Bromage H, Bott MJ, Toyooka S, Zauderer M, Ladanyi M., Free PMC Article | 05/6/2024 |
| Circ_0087851 suppresses colorectal cancer malignant progression through triggering miR-593-3p/BAP1-mediated ferroptosis. | Circ_0087851 suppresses colorectal cancer malignant progression through triggering miR-593-3p/BAP1-mediated ferroptosis.
Huang M, Gao T, Chen X, Yi J, Zhou X., Free PMC Article | 05/6/2024 |
| Functional assay for assessment of pathogenicity of BAP1 variants. | Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE, Backlund MP, Kivelä TT, Turunen JA., Free PMC Article | 02/22/2024 |
| Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma. | Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.
Takeda K, Bastacky S, Dhir R, Mohebnasab M, Quiroga-Garza GM. | 02/9/2024 |
| Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1. | Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1.
Wijdeven RH, Luk SJ, Schoufour TAW, van der Zanden SY, Cabezuelo M, Heemskerk MHM, Neefjes J. | 01/26/2024 |
| Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma. | Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.
Chen Y, Du X, Gao Y, Wu H, Zhao H, Su Y., Free PMC Article | 12/20/2023 |
| Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology. | Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.
Aydogdu G, Özekinci S. | 11/7/2023 |
| BAP1 promotes osteoclast function by metabolic reprogramming. | BAP1 promotes osteoclast function by metabolic reprogramming.
Rohatgi N, Zou W, Li Y, Cho K, Collins PL, Tycksen E, Pandey G, DeSelm CJ, Patti GJ, Dey A, Teitelbaum SL., Free PMC Article | 09/28/2023 |
| BAP1 mutations inhibit the NF-kappaB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma. | BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
Zhang C, Wu S., Free PMC Article | 09/20/2023 |
| BAP1 as a guardian of genome stability: implications in human cancer. | BAP1 as a guardian of genome stability: implications in human cancer.
Kwon J, Lee D, Lee SA., Free PMC Article | 08/25/2023 |
| Investigating the Role of FoxP3 in Renal Cell Carcinoma Metastasis with BAP1 or SEDT2 Mutation. | Investigating the Role of FoxP3 in Renal Cell Carcinoma Metastasis with BAP1 or SEDT2 Mutation.
Xu S, Hu X, Chong Y, Zhu G., Free PMC Article | 08/14/2023 |
| Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1. | Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.
Thomas JF, Valencia-Sánchez MI, Tamburri S, Gloor SL, Rustichelli S, Godínez-López V, De Ioannes P, Lee R, Abini-Agbomson S, Gretarsson K, Burg JM, Hickman AR, Sun L, Gopinath S, Taylor HF, Sun ZW, Ezell RJ, Vaidya A, Meiners MJ, Cheek MA, Rice WJ, Svetlov V, Nudler E, Lu C, Keogh MC, Pasini D, Armache KJ., Free PMC Article | 08/11/2023 |
| Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing. | Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L, Ingalls C, Ansari A, Porteus C, Donenberg TR, Sussman DA, Cebulla CM, Abdel-Rahman MH., Free PMC Article | 06/22/2023 |
| BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study. | BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.
Friedhoff J, Schneider F, Jurcic C, Endris V, Kirchner M, Sun A, Bolnavu I, Pohl L, Teroerde M, Kippenberger M, Schwab C, Kaczorowski A, Zschäbitz S, Jäger D, Hohenfellner M, Stenzinger A, Duensing A, Duensing S., Free PMC Article | 05/30/2023 |
| Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. | Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss.
Rüland L, Andreatta F, Massalini S, Chuva de Sousa Lopes S, Clevers H, Hendriks D, Artegiani B., Free PMC Article | 05/9/2023 |
| BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature. | BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature.
Landry AP, Wang JZ, Nassiri F, Patil V, Gao A, Zadeh G. | 04/24/2023 |